U.S. markets closed
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow 30

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     
  • Crude Oil

    61.66
    -1.87 (-2.94%)
     
  • Gold

    1,733.00
    -42.40 (-2.39%)
     
  • Silver

    26.70
    -0.98 (-3.56%)
     
  • EUR/USD

    1.2088
    -0.0099 (-0.81%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • GBP/USD

    1.3921
    -0.0091 (-0.65%)
     
  • USD/JPY

    106.5500
    +0.3200 (+0.30%)
     
  • BTC-USD

    45,705.22
    -2,761.23 (-5.70%)
     
  • CMC Crypto 200

    913.01
    -20.13 (-2.16%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

New Strong Sell Stocks for December 15th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Air Products and Chemicals, Inc. APD provides atmospheric gases, process and specialty gases, equipment, and services. The Zacks Consensus Estimate for its current year earnings has been revised 6.9% downward over the last 30 days.

Daré Bioscience, Inc. DARE is a clinical-stage biopharmaceutical company that focuses on developing and marketing women's reproductive health products. The Zacks Consensus Estimate for its current year earnings has been revised 13.2% downward over the last 30 days.

Energy Fuels Inc. UUUU engages in the extraction, recovery, exploration, and sale of conventional and in situ uranium recovery. The Zacks Consensus Estimate for its current year earnings has been revised 38.9% downward over the last 30 days.

Global Blood Therapeutics, Inc. GBT is a clinical-stage biopharmaceutical company that engages in the discovery, development, and delivery of treatments for underserved patient. The Zacks Consensus Estimate for its current year earnings has been revised 2.1% downward over the last 30 days.

CyberArk Software Ltd. CYBR develops, markets, and sales software-based security solutions and services. The Zacks Consensus Estimate for its current year earnings has been revised 0.6% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report
 
Energy Fuels Inc (UUUU) : Free Stock Analysis Report
 
CyberArk Software Ltd. (CYBR) : Free Stock Analysis Report
 
Global Blood Therapeutics, Inc. (GBT) : Free Stock Analysis Report
 
Dare Bioscience, Inc. (DARE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research